Secondary immune deficiency. Do we always need immunomodulators?

Abstract

Respiratory infectious diseases represent one of the most common pathologies in outpatient care. Use of immunomodulators in multimodal treatment of infectious and inflammatory diseases has been widely discussed recently. Since immune modulation therapy is auxiliary and could not substitute etiotropic drugs, the limits for the use of immunomodulators in the treatment of infectious diseases should be clearly defined. Patients with immune deficiencies constitute a special risk group for infectious diseases. Both etiotropic and immunomodulatory therapy for such patients should be selected very carefully. The review summarizes data on immunomodulators used in Russia and discusses conditions for prescribing immunomodulatory therapy.

Keywords

• вторичная иммунная недостаточность
• инфекционно-воспалительные заболевания
• иммуномодуля-торы
• острые респираторные заболевания
• secondary immune deficiency
• infectious and inflammatory diseases
• immune modulators
• acute respiratory diseases